MedPath

Remote Ischaemic Preconditioning to Prevent Dialysis Induced Cardiac Injury

Phase 2
Terminated
Conditions
Hemodialysis
Cardiovascular Diseases
Interventions
Other: Remote Ischaemic Preconditioning
Registration Number
NCT02630355
Lead Sponsor
Western University, Canada
Brief Summary

This study evaluates the use of remote ischaemic preconditioning for the prevention of dialysis induced cardiac injury. The study uses four arms to test different frequencies of application to ascertain which, if any, is most successful at reducing dialysis induced cardiac injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
32
Inclusion Criteria
  1. Patients having haemodialysis treatment at least 3 times per week at a London Health Sciences Centre facility
  2. Male and female, age≥16 years old.
Exclusion Criteria
  1. Not meeting inclusion criteria
  2. Exposure to haemodialysis for <90 days prior to recruitment
  3. Severe heart failure (New York Heart Association grade IV)
  4. Cardiac transplant recipients
  5. Mental incapacity to consent
  6. Declined to participate
  7. Taking cyclosporin
  8. Taking ATP-sensitive potassium channel opening or blocking drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low IntensityRemote Ischaemic PreconditioningInflation of blood pressure cuff in lower limb to 200mmHg for two cycles of 5 minute inflation and then deflation.
Standard IntensityRemote Ischaemic PreconditioningInflation of blood pressure cuff in lower limb to 200mmHg for four cycles of 5 minute inflation and then deflation.
ControlRemote Ischaemic PreconditioningInflation of blood pressure cuff in lower limb to 40mmHg for four cycles of 5 minutes inflation and then deflation
High IntensityRemote Ischaemic PreconditioningInflation of blood pressure cuff in lower limb to 200mmHg for four cycles of 5 minute inflation and deflation on weekly basis for four consecutive weeks.
Primary Outcome Measures
NameTimeMethod
The primary outcome will be a reduction in the number of left ventricular segments undergoing a greater than 30% reduction in longitudinal strain as detected by echocardiography at final study visit4 weeks
Secondary Outcome Measures
NameTimeMethod
Change in Troponin-T, Plasma IL-6 and N-Type proBNP at intervention, first follow-up and final visitup to 4 weeks
Number of segments undergoing >30% reduction in longitudinal strain at intervention, week 1, week 2 and week 3 visitsup to 3 weeks
Difference between pre and peak global longitudinal strain at intervention, week 1, week 2 and week 3 visitsup to 3 weeks
Change in pre-dialysis global longitudinal strain between baseline and final study visitbetween 1 and 4 weeks
© Copyright 2025. All Rights Reserved by MedPath